DOI QR코드

DOI QR Code

Intraarterial Nimodipine Infusion to Treat Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage

  • Kim, Jong-Hoon (Department of Neurosurgery, Gyeongsang National University School of Medicine) ;
  • Park, In-Sung (Department of Neurosurgery, Gyeongsang National University School of Medicine) ;
  • Park, Kyung-Bum (Department of Neurosurgery, Gyeongsang National University School of Medicine) ;
  • Kang, Dong-Ho (Department of Neurosurgery, Gyeongsang National University School of Medicine) ;
  • Hwang, Soo-Hyun (Department of Neurosurgery, Gyeongsang National University School of Medicine)
  • Published : 2009.09.28

Abstract

Objective : Cerebral vasospasm leading to cerebral ischemic infarction is a major cause of morbidity and mortality in the patients who suffer with aneurysmal subarachnoid hemorrhage. Despite adequate treatment, some patients deteriorate and they develop symptomatic vasospasm. The objective of the present study was to investigate the efficacy and clinical outcome of intraarterial nimodipine infusion on symptomatic vasospasm that is refractory to hemodynamic therapy. Methods : We retrospectively reviewed the procedure reports, the clinical charts and the transcranial doppler, computed tomography and digital subtraction angiography results for the patients who underwent endovascular treatment for symptomatic cerebral vasospasm due to aneurysmal SAH. During the 36 months between Jan. 2005 and Dec. 2007, 19 patients were identified who had undergone a total of 53 procedures. We assessed the difference in the arterial vessel diameter, the blood flow velocity and the clinical outcome before and after these procedures. Results : Vascular dilatation was observed in 42 of 53 procedures. The velocities of the affected vessels before and after procedures were available in 33 of 53 procedures. Twenty-nine procedures exhibited a mean decrease of 84.1 cm/s. We observed clinical improvement and an improved level of consciousness with an improved GCS score after 23 procedures. Conclusion : Based on our results, the use of intraarterial nimodipine is effective and safe in selected cases of vasospasm following aneurysmal SAH. Prospective, randomized studies are needed to confirm these results.

Keywords

References

  1. Baldwin ME, Macdonald RL, Huo D, Novakovic RL, Goldenberg FD, Frank JI, et al. : Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 35 : 2506-2511, 2004 https://doi.org/10.1161/01.STR.0000144654.79393.cf
  2. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, et al. : Intra-arterial Nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid haemorrhage : preliminary results. AJNR Am J Neuroradiol 25 : 1067-1076, 2004
  3. B$\ddot{o}$ker DK, Solymosi L, Wassmann H : Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid haemorrhage with nimodipine. Report on 3 cases. Neurochirurgia (Stuttg) 28 Suppl 1 : 118-120, 1985
  4. Chow M, Dumont AS, Kassell NF : Endothelin receptor antagonists and cerebral vasospasm: an update. Neurosurgery 51 : 1333-1341; discussion 1342, 2002 https://doi.org/10.1097/00006123-200212000-00002
  5. Findlay JM, Macdonald RL, Weir BK : Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 3 : 336-361, 1991
  6. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F : Selective intraarterial Nimodipine treatment in an experimental subarachnoid haemorrhage model. AJNR Am J Neuroradiol 26 : 1357-1362, 2005
  7. Fujii Y, Takahashi A, Ezura M, Mizoi K : Balloon angioplasty immediately after surgical clipping for symptomatic vasospasm on admission. Report of four cases. Neurosurg Rev 18 : 79-84, 1995 https://doi.org/10.1007/BF00417662
  8. Grotenhuis JA, Bettag W, Fiebach BJ, Fiebach BJ, Dabir K : Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH. A preliminary report. J Neurosurg 61 : 231-240, 1984 https://doi.org/10.3171/jns.1984.61.2.0231
  9. Harrod CG, Bendok BR, Batjer HH : Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage : a review. Neurosurgery 56 : 633-654; discussion 633- 654, 2005 https://doi.org/10.1227/01.NEU.0000156644.45384.92
  10. Hui C, Lau KP : Efficacy of intra-arterial Nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 60 : 1030-1036, 2005 https://doi.org/10.1016/j.crad.2005.04.004
  11. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K : Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77 : 842- 847, 1992 https://doi.org/10.3171/jns.1992.77.6.0842
  12. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL : The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1 : overall management results. J Neurosurg 73 : 18-36, 1990 https://doi.org/10.3171/jns.1990.73.1.0018
  13. Linn FH, Rinkel GJ, Algra A, van Gijn J : Incidence of subarachnoid hemorrhage : role of region, year, and rate of computed tomography : a meta-analysis. Stroke 27 : 625-629, 1996 https://doi.org/10.1161/01.STR.27.4.625
  14. Macdonald LR, Weir B : Epidemiology in cerebral vasospasm. San Diego (CA) : Academic Press, 2001, pp17-43
  15. Meyer FB : Calcium antagonists and vasospasm. Neurosurg Clin N Am 1 : 367-376, 1990
  16. Milburn JM, Moran CJ, Cross DT 3rd, Diringer MN, Pilgram TK, Dacey RG Jr : Increase in diameters of vasospastic intracranial vessels by intraarterial papaverine administration. J Neurosurg 88 : 38-42, 1998 https://doi.org/10.3171/jns.1998.88.1.0038
  17. Mindea SA, Yang BP, Bendok BR, Miller JW, Batjer HH : Endovascular treatment strategies for cerebral vasospasm. Neurosurg Focus 21 : E13, 2006
  18. Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht ST : The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage : a pilot study. J Neurosurg 91 : 51-58, 1999 https://doi.org/10.3171/jns.1999.91.1.0051
  19. Numaguchi Y, Zoarski GH, Clouston JE, Zagardo MT, Simard JM, Aldrich EF, et al. : Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 39 : 751-759, 1997 https://doi.org/10.1007/s002340050501
  20. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF : Intraarterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 42 : 1256-1264 ; discussion 1264-1267, 1998 https://doi.org/10.1097/00006123-199806000-00031
  21. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J : Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 25 : CD000277, 2005
  22. Schuknecht B, Fandino J, Yüksel C, Yonekawa Y, Valavanis A : Endovascular treatment of cerebral vasospasm : assessment of treatment effect by cerebral angiography and transcranial colour Doppler sonography. Neuroradiology 41 : 453-462, 1999 https://doi.org/10.1007/s002340050784
  23. Treggiari-Venzi MM, Suter PM, Romand JA : Review of medical prevention of vasospasm after aneurysmal subarachnoid haemorrhage : a problem of neurointensive care. Neurosurgery 48 : 249-261; discussion 261-262, 2001 https://doi.org/10.1097/00006123-200102000-00001
  24. Yasudah SU, Tietze KJ : Nimodipine in the treatment of subarachnoid hemorrhage. DICP 23 : 451-455, 1989

Cited by

  1. Intra-Arterial Nimodipine Infusion for Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage vol.17, pp.2, 2009, https://doi.org/10.1177/159101991101700205
  2. Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report vol.33, pp.3, 2011, https://doi.org/10.1179/016164110x12759951866830
  3. Nimodipine potentiates the analgesic effect of morphine in the rat hot-plate test: Implications in the treatment of pain vol.55, pp.4, 2009, https://doi.org/10.4103/0019-5049.84843
  4. Intracranial drug delivery for subarachnoid hemorrhage vol.3, pp.1, 2009, https://doi.org/10.4155/tde.11.124
  5. Effect of Intra-Arterial Nimodipine Infusion for the Treatment of Symptomatic Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage vol.66, pp.6, 2012, https://doi.org/10.3348/jksr.2012.66.6.501
  6. Clinical Variables Correlated with Numbers of Intra-arterial Nimodipine Infusion in Patients with Medically Refractory Cerebral Vasospasm vol.17, pp.3, 2009, https://doi.org/10.7461/jcen.2015.17.3.157
  7. Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome vol.29, pp.1, 2009, https://doi.org/10.1177/1971400915626429
  8. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage? vol.30, pp.4, 2016, https://doi.org/10.3109/02688697.2016.1161172
  9. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage vol.30, pp.5, 2009, https://doi.org/10.3109/02688697.2016.1173193
  10. Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage vol.30, pp.4, 2009, https://doi.org/10.1515/romneu-2016-0074
  11. Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage vol.30, pp.4, 2009, https://doi.org/10.1515/romneu-2016-0074
  12. Effect of Intra-arterial Nimodipine on Cerebral Oxygen Saturation and Systemic Hemodynamic Indices in Patients With Cerebral Vasospasm: A Prospective Cohort Study vol.32, pp.2, 2009, https://doi.org/10.1097/ana.0000000000000570
  13. Solid Dispersion: A Mechanistic and Realistic Approach on Antihypertensive Drug as a Drug Carrier System vol.19, pp.5, 2021, https://doi.org/10.1089/adt.2020.1055